Please login to the form below

Not currently logged in
Email:
Password:

FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics

Scott GottliebSpeech coincides with Biosimilars Action Plan

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Bayer's Eylea remains the drug to beat, however

AstraZeneca joins Merck in Brexit stockpiling effort

AstraZeneca AZSays it is increasing stores of medicines by around 20%

Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

Novartis dayA round up from pharma, biotech and healthcare

Brexit

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Brexit

Communiqué Awards 2018 - Photo Gallery

View the 2018 Winners and Photo Galleries



Novartis launch NET cancer community app

Galaxies of Hope aims to provide support to cancer patients

Galaxies of Hope

Healthcare Comms appointments

Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWA\WorldHealth London sees Andy Hayley and Dick Dunford return

Marianne

Malthus’ orphans

Firms focusing on small, high-profit niches risk falling into a 200-year-old trap

darwins medicine

No results were found

Pharma industry appointments

Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.

Dave Lemus

Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte

Alexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media

Sanofi Ambien

Trump attempts The Art of the Deal with pharma

Yet incendiary language, bullying and threats rarely lead to a deal

No results were found

Doing more with less: when ‘client-centricity’ matters most

At a time when companies face continued downward pressure on operational expenditure, doing ‘more with less’ is becoming a fact of life

Angela Mahaney

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics